Access Pharmaceuticals to Conduct Conference Call to Update Financial... ( DALLAS March 10 /- ACCESS PHARMAC...)

Access Pharmaceuticals to Conduct Conference Call to Update Financial Community

Date:3/10/2008

DALLAS, March 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its management team has scheduled a conference call for March 13, 2008 at 10:00 a.m. ET to update the financial community about the status of its clinical trial programs as well as its business opportunities.

Interested parties may participate in the call by dialing (877) 407-8293; callers outside the U.S. may participate by dialing (201) 689-8349 about 5-10 minutes prior to 10:00 a.m. ET. The conference call will also be available on replay starting at 12:00 noon ET on March 13, 2008, and ending on April 13, 2008. For the replay, U.S. participants please dial (877) 660-6853 (replay account # 294, replay conference #278416). The access number for the replay for callers outside the U.S. is (201) 612-7415 (replay account # 294, replay conference # 278416).

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM) -- mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additiona
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
2. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
3. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
4. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac

Post Your Comments:

(Date:5/22/2013)... Jersey , 22. Mai 2013 /PRNewswire/ ... Fähigkeitsentwicklung und Beratung, gab heute bekannt, dass ... Chris Geraghty , zum Hauptgeschäftsführer ernannt ... Jahre im Industriebereich wo er zahlreiche Führungspositionen ... von Ray Baxter an, der als Kepner-Tregoe ...

(Date:5/22/2013)... 2013 Z-Medica, a leading developer and marketer ... first-ever line of products designed to meet the unique ... ® EMS 4x4 Dressing, QuikClot ® EMS ... Gauze™, all custom-designed to help responders stop bleeding fast ... to a hospital or trauma center. The line includes ...

(Date:5/22/2013)... -- MGT Capital Investments, Inc. (NYSE MKT: MGT) announced today ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... the Grand Hyatt Hotel. Robert Ladd ... and answer questions. (Logo: http://photos.prnewswire.com/prnh/20130409/NY91046LOGO ... begin at 9:30 a.m. EDT. MGT,s latest presentation materials ...

Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3 Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4

[0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer [0] Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services [0] MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference

... University of Bari, Italy, concluded that treating patients after ... (SVR) and protects them from liver-related deaths. The purpose ... outcomes of patients posttransplant who underwent antiviral therapy for ... graft. The use in clinical practice ...

... SPRING, Md., Oct. 29 The U.S. Food ... an injectable antibiotic to treat adults with community ... and skin structure infections (ABSSSI), including methicillin-resistant ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...

Cached Medicine Technology:Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes 2 FDA Approves Teflaro for Bacterial Infections 2 FDA Approves Teflaro for Bacterial Infections 3

Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes FDA Approves Teflaro for Bacterial Infections

(Date:5/22/2013)... (PRWEB) May 22, 2013 On May 16, ... or more on average, a funeral concierge can help families ... other benefits. Funeral Financials announces their top ... household income in the U.S. having dropped 7.3 ... Sentier Research, the average funeral costs 12.6% of an average ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 TWITTER: @the_USO ... Family Tour together, heading to 8 countries in the next 6 ... Street, Cookie Monster and Members of Congress came together to show ... assembled 2,000 USO Care Packages for distribution to our ... celebrate the five-year partnership of Sesame Street and the USO as ...

(Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...

(Date:5/22/2013)... May 22, 2013 Successful Therapy ... Patricia O’Laughlin Psychotherapy in the Silver Lake community ... all ages as progression to existing Parents and ... ages into parenting therapy has always been suggested, ... O’Laughlin Psychotherapy now specializes in all aspects of ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...

[0] Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge [0] The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC [0] Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners [0] Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... the same way it responds to winning money and eating ... brain,s reward circuitry. , "We may be ... Matthew D. Lieberman, UCLA associate professor of psychology and a ... a fair offer activates the same brain circuitry as when ...

... April 21 Committed to the safety and,well-being of ... evaluate the recent concerns of the New Jersey Department ... closing of three playing,fields over suspected high lead levels., ... Davis Lee (Ph.D.,Synthetic Organic Chemistry) assert that there is ...

... rate was lower than with malignancies diagnosed on face, ears, ... most deadly melanoma skin cancers occur on the scalp and ... (UNC) study. , Researchers analyzed 51,704 melanoma cases in the ... melanomas died at 1.84 times the rate of patients with ...

... April 21 Versus,Technology, Inc., (Versus) announces ... Kidney Institute that will combine Versus,Real-time Location ... Glickman Urological & Kidney Institute,s clinical,workflow expertise ... The collaboration will develop and document ...

... costs and ... improve productivity, CHICAGO, April 21 ... annually(1), the amount,these families spend on employer-sponsored health care per year ... and,Talent Survey revealed that the median annual contribution for family,healthcare coverage ...

... for Health(R) Dental Health Center Highlights the Importance of Oral ... ... April 21 National dental insurer,United Concordia today unveiled the ... http://www.unitedconcordia.com, empowering,consumers to take charge of their oral ...

Cached Medicine News:Health News:Brain reacts to fairness as it does to money and chocolate 2 Health News:Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields 2 Health News:Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields 3 Health News:Melanomas on Scalp and Neck More Deadly 2 Health News:Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model 2 Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 2 Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 3 Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 4 Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 5 Health News:United Concordia Launches New Online Dental Health Center 2

Brain reacts to fairness as it does to money and chocolate Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields Melanomas on Scalp and Neck More Deadly Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting United Concordia Launches New Online Dental Health Center

Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....

Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....

Used to introduce balloon, electrode, closed or non-tapered end and other catheters....

Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....

Medicine Products:

FLEXOR CHECK-FLO Introducer Set Large Valve Assembly with Radiopaque Band CHECK-FLO Performer Introducers CHILDRENS HOSPITAL BOSTON MODIFICATION CHECK-FLO PERFORMER INTRODUCER SETS Avanti+ Catheter Sheath Introducer